Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses - PubMed (original) (raw)
. 1997 Dec;71(12):8999-9007.
doi: 10.1128/JVI.71.12.8999-9007.1997.
A L Edinger, M Sharron, M Samson, B Lee, J F Berson, Y Yi, B Margulies, R G Collman, B J Doranz, M Parmentier, R W Doms
Affiliations
- PMID: 9371556
- PMCID: PMC230200
- DOI: 10.1128/JVI.71.12.8999-9007.1997
Utilization of chemokine receptors, orphan receptors, and herpesvirus-encoded receptors by diverse human and simian immunodeficiency viruses
J Rucker et al. J Virol. 1997 Dec.
Abstract
Human immunodeficiency virus type 1 (HIV-1) requires both CD4 and a coreceptor to infect cells. Macrophage-tropic (M-tropic) HIV-1 strains utilize the chemokine receptor CCR5 in conjunction with CD4 to infect cells, while T-cell-tropic (T-tropic) strains generally utilize CXCR4 as a coreceptor. Some viruses can use both CCR5 and CXCR4 for virus entry (i.e., are dual-tropic), while other chemokine receptors can be used by a subset of virus strains. Due to the genetic diversity of HIV-1, HIV-2, and simian immunodeficiency virus (SIV) and the potential for chemokine receptors other than CCR5 or CXCR4 to influence viral pathogenesis, we tested a panel of 28 HIV-1, HIV-2, and SIV envelope (Env) proteins for the ability to utilize chemokine receptors, orphan receptors, and herpesvirus-encoded chemokine receptor homologs by membrane fusion and virus infection assays. While all Env proteins used either CCR5 or CXCR4 or both, several also used CCR3. Use of CCR3 was strongly dependent on its surface expression levels, with a larger number of viral Env proteins being able to utilize this coreceptor at the higher levels of surface expression. ChemR1, an orphan receptor recently shown to bind the CC chemokine I309 (and therefore renamed CCR8), was expressed in monocyte and lymphocyte cell populations and functioned as a coreceptor for diverse HIV-1, HIV-2, and SIV Env proteins. Use of ChemR1/CCR8 by SIV strains was dependent in part on V3 loop sequences. The orphan receptor V28 supported Env-mediated cell-cell fusion by four T- or dual-tropic HIV-1 and HIV-2 strains. Three additional orphan receptors failed to function for any of the 28 Env proteins tested. Likewise, five of six seven-transmembrane-domain receptors encoded by herpesviruses did not support Env-mediated membrane fusion. However, the chemokine receptor US28, encoded by cytomegalovirus, did support inefficient infection by two HIV-1 strains. These findings indicate that additional chemokine receptors can function as HIV and SIV coreceptors and that surface expression levels can strongly influence coreceptor use.
Similar articles
- Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
Edinger AL, Hoffman TL, Sharron M, Lee B, O'Dowd B, Doms RW. Edinger AL, et al. Virology. 1998 Sep 30;249(2):367-78. doi: 10.1006/viro.1998.9306. Virology. 1998. PMID: 9791028 - Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
Hill CM, Deng H, Unutmaz D, Kewalramani VN, Bastiani L, Gorny MK, Zolla-Pazner S, Littman DR. Hill CM, et al. J Virol. 1997 Sep;71(9):6296-304. doi: 10.1128/JVI.71.9.6296-6304.1997. J Virol. 1997. PMID: 9261346 Free PMC article. - Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood.
Singh A, Besson G, Mobasher A, Collman RG. Singh A, et al. J Virol. 1999 Aug;73(8):6680-90. doi: 10.1128/JVI.73.8.6680-6690.1999. J Virol. 1999. PMID: 10400765 Free PMC article. - Roles of chemokines and chemokine receptors in HIV-1 infection.
Murakami T, Yamamoto N. Murakami T, et al. Int J Hematol. 2000 Dec;72(4):412-7. Int J Hematol. 2000. PMID: 11197206 Review. - Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands.
Simmons G, Reeves JD, Hibbitts S, Stine JT, Gray PW, Proudfoot AE, Clapham PR. Simmons G, et al. Immunol Rev. 2000 Oct;177:112-26. doi: 10.1034/j.1600-065x.2000.17719.x. Immunol Rev. 2000. PMID: 11138769 Review.
Cited by
- The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses.
Bannert N, Schenten D, Craig S, Sodroski J. Bannert N, et al. J Virol. 2000 Dec;74(23):10984-93. doi: 10.1128/jvi.74.23.10984-10993.2000. J Virol. 2000. PMID: 11069993 Free PMC article. - Characterization of novel simian immunodeficiency viruses from red-capped mangabeys from Nigeria (SIVrcmNG409 and -NG411).
Beer BE, Foley BT, Kuiken CL, Tooze Z, Goeken RM, Brown CR, Hu J, St Claire M, Korber BT, Hirsch VM. Beer BE, et al. J Virol. 2001 Dec;75(24):12014-27. doi: 10.1128/JVI.75.24.12014-12027.2001. J Virol. 2001. PMID: 11711592 Free PMC article. - Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.
Mörner A, Björndal A, Albert J, Kewalramani VN, Littman DR, Inoue R, Thorstensson R, Fenyö EM, Björling E. Mörner A, et al. J Virol. 1999 Mar;73(3):2343-9. doi: 10.1128/JVI.73.3.2343-2349.1999. J Virol. 1999. PMID: 9971817 Free PMC article. - V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1.
Chan SY, Speck RF, Power C, Gaffen SL, Chesebro B, Goldsmith MA. Chan SY, et al. J Virol. 1999 Mar;73(3):2350-8. doi: 10.1128/JVI.73.3.2350-2358.1999. J Virol. 1999. PMID: 9971818 Free PMC article. - Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.
König RR, Flory E, Steidl S, Neumann J, Coulibaly C, Holznagel E, Holzammer S, Norley S, Cichutek K. König RR, et al. J Virol. 2002 Nov;76(21):10627-36. doi: 10.1128/jvi.76.21.10627-10636.2002. J Virol. 2002. PMID: 12368305 Free PMC article.
References
- Eur J Immunol. 1996 Dec;26(12):3021-8 - PubMed
- J Virol. 1997 Feb;71(2):1692-6 - PubMed
- Nature. 1997 Jan 23;385(6614):347-50 - PubMed
- J Clin Invest. 1997 Jan 15;99(2):178-84 - PubMed
- Nature. 1997 Feb 13;385(6617):645-9 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- AI-40880/AI/NIAID NIH HHS/United States
- R01 AI035502/AI/NIAID NIH HHS/United States
- AI-35383/AI/NIAID NIH HHS/United States
- R01 AI040880/AI/NIAID NIH HHS/United States
- AI-38225/AI/NIAID NIH HHS/United States
- T32 NS007392/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials